Skip to main content
MorphoSys AG logo

MorphoSys AG — Investor Relations & Filings

Ticker · MOR ISIN · DE000A3H2XW6 LEI · 529900493806K77LRE72 F Manufacturing
Open in API
Filings indexed 1,418 across all filing types
Latest filing 2024-06-05 Declaration of Voting R…
Country DE Germany
Listing F MOR

About MorphoSys AG

https://www.morphosys.com/

MorphoSys AG is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of innovative medicines, primarily for cancer patients. The company specializes in creating therapeutic monoclonal antibodies, utilizing its long-standing expertise and proprietary technology platforms to generate fully human antibodies. Its research and development efforts are concentrated on building a pipeline of novel treatments to address significant unmet medical needs in oncology. In February 2024, Novartis entered into an agreement to acquire MorphoSys, aiming to integrate its antibody technologies and oncology pipeline.

Recent filings

Filing Released Lang Actions
Declaration of Voting Results & Voting Rights Announcements 2024
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is explicitly titled 'Voting Rights Announcements' and contains detailed tables regarding the 'Notification of Major Holdings' under German securities law (WpHG). It reports changes in voting rights percentages (both direct shares and instruments) held by UBS Group AG in MorphoSys AG, crossing specific thresholds on May 30, 2024. This content directly matches the definition of a filing related to changes in significant share ownership, which corresponds to the Major Shareholding Notification category (MRQ). Although it is a regulatory announcement disseminated via EQS, the specific subject matter is the change in major holdings, making MRQ more precise than the general RNS fallback.
2024-06-05 English
Declaration of Voting Results & Voting Rights Announcements 2024
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is explicitly titled 'Notification of Major Holdings' and contains detailed sections regarding the 'acquisition/disposal of shares with voting rights' and 'instruments according to Sec. 38 (1)'. It reports changes in the percentage of voting rights held by a major shareholder (The Goldman Sachs Group, Inc.) in MorphoSys AG, referencing specific German securities law articles (WpHG). This structure perfectly matches the definition of a Major Shareholding Notification, which is categorized as 'MRQ' in the provided schema.
2024-06-04 English
Declaration of Voting Results & Voting Rights Announcements 2024
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is explicitly titled 'Voting Rights Announcements' and contains detailed tables reporting changes in voting rights percentages and the total number of voting rights held by a major shareholder (The Goldman Sachs Group, Inc.) in MorphoSys AG, referencing specific sections of the German Securities Trading Act (WpHG). This directly corresponds to the definition of a Major Shareholding Notification, which tracks changes in significant ownership thresholds. Although the document mentions 'Voting Rights Announcements' in the header, the content structure (Section 6: Total positions, Section 7: Details on total positions, tracking share and instrument holdings) aligns perfectly with the 'Major Shareholding Notification' category (MRQ).
2024-06-04 English
Declaration of Voting Results & Voting Rights Announcements 2024
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is explicitly titled 'Notification of Major Holdings' and references German Securities Trading Act (WpHG) regulations concerning voting rights. Section 6 details the 'Total positions' regarding the percentage of voting rights held by an individual (Pablo Legorreta), showing a change from a previous notification. This type of filing, which reports changes in significant share ownership thresholds, directly corresponds to the definition of Major Shareholding Notification (MRQ). Although it mentions 'Voting Rights Announcements' in the header, the core content is the change in holding percentage, making MRQ the most precise fit over DVA (which is for voting results) or DIRS (which is for director's personal trades, though this is an insider, the focus is on the holding percentage change).
2024-06-04 English
Major Shareholding Notification 2024
Major Shareholding Notification Classification · 1% confidence The document is explicitly titled 'Voting Rights Announcements' and contains detailed tables reporting changes in share ownership ('Notification of Major Holdings') by a specific legal entity (Royalty Pharma PLC) in MorphoSys AG, referencing German Securities Trading Act (WpHG) sections. This directly corresponds to the definition of a notification of changes in significant share ownership levels crossing thresholds. The closest matching category is Major Shareholding Notification (MRQ). Although the header mentions 'Voting Rights Announcements', the content is a formal notification of a holding change, which falls under MRQ, rather than the general results of a vote (DVA).
2024-06-04 English
Declaration of Voting Results & Voting Rights Announcements 2024
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is explicitly titled 'Voting Rights Announcements' and contains detailed sections regarding the 'Notification of Major Holdings' under German securities law (WpHG). It reports changes in the percentage of voting rights held by UBS Group AG in MorphoSys AG, crossing a threshold on May 24, 2024. This content directly corresponds to the definition of a notification regarding changes in significant share ownership levels, which aligns best with the Major Shareholding Notification category (MRQ). Although it is a regulatory announcement disseminated via EQS News, the specific subject matter (major holdings/voting rights change) is more precise than the general 'RNS' fallback.
2024-05-31 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.